Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vincent T Ho

Showing results (111-120 of 227) with videos related to

Pageof 23
Sort By:
Science Translational Medicine|April 5, 2013
Low-dose interleukin-2 therapy restores regulatory T cell homeostasis in patients with chronic graft-versus-host diseaseKen-ichi Matsuoka, John Koreth, Haesook T Kim, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 15, 2014
A phase II study of bortezomib plus prednisone for initial therapy of chronic graft-versus-host diseaseAlex F Herrera, Haesook T Kim, Bhavjot Bindra, et al.
Blood Advances|January 3, 2023
Lower incidence of chronic GVHD observed after transplantation with cryopreserved unrelated allogeneic stem cellsKatie Maurer, Haesook T Kim, Heather M Garrity, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 18, 2015
Impact of conditioning regimen on outcomes for patients with lymphoma undergoing high-dose therapy with autologous hematopoietic cell transplantationYi-Bin Chen, Andrew A Lane, Brent Logan, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 1, 2009
Biologic activity of irradiated, autologous, GM-CSF-secreting leukemia cell vaccines early after allogeneic stem cell transplantationVincent T Ho, Matthew Vanneman, Haesook Kim, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 12, 2015
Phase II Trial of Reduced-Intensity Busulfan/Clofarabine Conditioning with Allogeneic Hematopoietic Stem Cell Transplantation for Patients with Acute Myeloid Leukemia, Myelodysplastic Syndromes, and Acute Lymphoid LeukemiaAreej El-Jawahri, Shuli Li, Karen K Ballen, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 4, 2019
Incidence, Predictors, and Outcomes of Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome after Reduced-Intensity Allogeneic Hematopoietic Cell TransplantationClinton Lewis, Haesook T Kim, Lindsey E Roeker, et al.
Blood Advances|January 4, 2018
Vaccination with autologous myeloblasts admixed with GM-K562 cells in patients with advanced MDS or AML after allogeneic HSCTVincent T Ho, Haesook T Kim, Natalie Bavli, et al.
American Journal of Hematology|June 13, 2025
Poor Engraftment After Posttransplant Cyclophosphamide Graft-Versus-Host DISAESE Prophylaxis in Patients With MyelofibrosisHaesook T Kim, Deborah J Liney, Kristen Rizza, et al.
Leukemia|January 25, 2021
Author Correction: Fit older adults with advanced myelodysplastic syndromes: who is most likely to benefit from transplant?Gregory A Abel, Haesook T Kim, Andrew Hantel, et al.
Pageof 23

Showing results (111-120 of 227) with videos related to

Sort By:
Pageof 23
Science Translational Medicine|April 5, 2013
Low-dose interleukin-2 therapy restores regulatory T cell homeostasis in patients with chronic graft-versus-host diseaseKen-ichi Matsuoka, John Koreth, Haesook T Kim, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 15, 2014
A phase II study of bortezomib plus prednisone for initial therapy of chronic graft-versus-host diseaseAlex F Herrera, Haesook T Kim, Bhavjot Bindra, et al.
Blood Advances|January 3, 2023
Lower incidence of chronic GVHD observed after transplantation with cryopreserved unrelated allogeneic stem cellsKatie Maurer, Haesook T Kim, Heather M Garrity, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 18, 2015
Impact of conditioning regimen on outcomes for patients with lymphoma undergoing high-dose therapy with autologous hematopoietic cell transplantationYi-Bin Chen, Andrew A Lane, Brent Logan, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 1, 2009
Biologic activity of irradiated, autologous, GM-CSF-secreting leukemia cell vaccines early after allogeneic stem cell transplantationVincent T Ho, Matthew Vanneman, Haesook Kim, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 12, 2015
Phase II Trial of Reduced-Intensity Busulfan/Clofarabine Conditioning with Allogeneic Hematopoietic Stem Cell Transplantation for Patients with Acute Myeloid Leukemia, Myelodysplastic Syndromes, and Acute Lymphoid LeukemiaAreej El-Jawahri, Shuli Li, Karen K Ballen, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 4, 2019
Incidence, Predictors, and Outcomes of Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome after Reduced-Intensity Allogeneic Hematopoietic Cell TransplantationClinton Lewis, Haesook T Kim, Lindsey E Roeker, et al.
Blood Advances|January 4, 2018
Vaccination with autologous myeloblasts admixed with GM-K562 cells in patients with advanced MDS or AML after allogeneic HSCTVincent T Ho, Haesook T Kim, Natalie Bavli, et al.
American Journal of Hematology|June 13, 2025
Poor Engraftment After Posttransplant Cyclophosphamide Graft-Versus-Host DISAESE Prophylaxis in Patients With MyelofibrosisHaesook T Kim, Deborah J Liney, Kristen Rizza, et al.
Leukemia|January 25, 2021
Author Correction: Fit older adults with advanced myelodysplastic syndromes: who is most likely to benefit from transplant?Gregory A Abel, Haesook T Kim, Andrew Hantel, et al.
Pageof 23